One year after Nigeria introduced the R21 malaria vaccine, health workers in Kebbi State are reporting a significant decline in malaria-related hospital admissions and child deaths.
At the Nassarawa Maternal and Child Health Centre in Birnin Kebbi, Maimunatu Abubakar recalls weeks when more than 12 children were admitted with malaria, especially during the rainy season. Today, that number has reduced to about four per week, with no recorded child deaths from malaria at the facility since June 2025.
Measurable drop in infections
Nigeria carries nearly 27 per cent of the global malaria burden, according to the World Health Organization, with Kebbi State recording the highest prevalence among children under five.
With support from Gavi, the Vaccine Alliance, UNICEF and WHO, Nigeria received one million doses of the R21 vaccine in 2024. Kebbi was allocated nearly 6 lakh doses for integration into routine immunisation.
According to the Kebbi State Primary Health Care Development Agency, more than 2 lakh children aged 5–23 months have received the first dose. Health officials say post-rollout assessments show a 50 per cent reduction in malaria infections across selected facilities.
Falling mortality rates
Authorities report that under-five mortality in Kebbi dropped from 8.97 per cent in January 2025 to 6.13 per cent by October. Infant mortality also declined during the same period.
Families are experiencing tangible relief. Nafisa Mohammed, a farmer from Baiti community, lost her first child to malaria a decade ago. Her youngest son, vaccinated in late 2024, has not fallen ill with malaria since receiving the jab.
The vaccine’s introduction has eased both emotional and financial burdens for low-income households, where treatment costs often strain limited incomes.
Community mobilisation continues
Officials are intensifying awareness campaigns through traditional leaders, religious institutions, radio and social media to ensure children complete all required doses.
The R21 vaccine’s early success signals renewed hope in the global fight against malaria, offering a lifeline to communities long burdened by the disease.
Comments are closed.